US Bancorp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.3M | Sell |
29,781
-69
| -0.2% | -$32.2K | 0.02% | 365 |
|
|
2025
Q4 | $13.5M | Sell |
29,850
-1,006
| -3% | -$434K | 0.02% | 378 |
|
|
2025
Q3 | $12.1M | Sell |
30,856
-2,727
| -8% | -$1.14M | 0.01% | 399 |
|
|
2025
Q2 | $15M | Buy |
33,583
+1,324
| +4% | +$610K | 0.02% | 369 |
|
|
2025
Q1 | $15.6M | Buy |
32,259
+1,916
| +6% | +$893K | 0.02% | 359 |
|
|
2024
Q4 | $12.2M | Buy |
30,343
+3,764
| +14% | +$1.74M | 0.02% | 400 |
|
|
2024
Q3 | $12.4M | Buy |
26,579
+2,273
| +9% | +$1.09M | 0.02% | 393 |
|
|
2024
Q2 | $11.4M | Buy |
24,306
+2,856
| +13% | +$1.24M | 0.02% | 399 |
|
|
2024
Q1 | $8.97M | Buy |
21,450
+2,288
| +12% | +$967K | 0.01% | 450 |
|
|
2023
Q4 | $7.8M | Buy |
19,162
+6,065
| +46% | +$2.24M | 0.01% | 476 |
|
|
2023
Q3 | $4.55M | Buy |
13,097
+1,383
| +12% | +$484K | 0.01% | 562 |
|
|
2023
Q2 | $4.12M | Sell |
11,714
-915
| -7% | -$308K | 0.01% | 588 |
|
|
2023
Q1 | $3.98M | Buy |
12,629
+183
| +1% | +$54.9K | 0.01% | 600 |
|
|
2022
Q4 | $3.59M | Sell |
12,446
-726
| -6% | -$221K | 0.01% | 627 |
|
|
2022
Q3 | $3.81M | Buy |
13,172
+578
| +5% | +$166K | 0.01% | 575 |
|
|
2022
Q2 | $3.55M | Sell |
12,594
-3,107
| -20% | -$832K | 0.01% | 622 |
|
|
2022
Q1 | $4.1M | Buy |
15,701
+1,512
| +11% | +$359K | 0.01% | 619 |
|
|
2021
Q4 | $3.12M | Buy |
14,189
+1,895
| +15% | +$368K | ﹤0.01% | 749 |
|
|
2021
Q3 | $2.23M | Sell |
12,294
-474
| -4% | -$92.5K | ﹤0.01% | 836 |
|
|
2021
Q2 | $2.58M | Sell |
12,768
-3,408
| -21% | -$713K | ﹤0.01% | 791 |
|
|
2021
Q1 | $3.48M | Buy |
16,176
+2,068
| +15% | +$454K | 0.01% | 651 |
|
|
2020
Q4 | $3.33M | Buy |
14,108
+922
| +7% | +$212K | 0.01% | 635 |
|
|
2020
Q3 | $3.59M | Buy |
13,186
+972
| +8% | +$268K | 0.01% | 570 |
|
|
2020
Q2 | $3.55M | Sell |
12,214
-328
| -3% | -$88.9K | 0.01% | 564 |
|
|
2020
Q1 | $2.98M | Buy |
12,542
+2,052
| +20% | +$471K | 0.01% | 564 |
|
|
2019
Q4 | $2.3M | Buy |
10,490
+477
| +5% | +$96.5K | 0.01% | 723 |
|
|
2019
Q3 | $1.7M | Buy |
10,013
+707
| +8% | +$125K | ﹤0.01% | 813 |
|
|
2019
Q2 | $1.71M | Buy |
9,306
+319
| +4% | +$55.8K | ﹤0.01% | 854 |
|
|
2019
Q1 | $1.65M | Buy |
8,987
+685
| +8% | +$127K | ﹤0.01% | 847 |
|
|
2018
Q4 | $1.38M | Buy |
8,302
+1,051
| +14% | +$182K | ﹤0.01% | 869 |
|
|
2018
Q3 | $1.4M | Sell |
7,251
-118
| -2% | -$21K | ﹤0.01% | 946 |
|
|
2018
Q2 | $1.25M | Sell |
7,369
-1,315
| -15% | -$204K | ﹤0.01% | 997 |
|
|
2018
Q1 | $1.42M | Buy |
8,684
+1,669
| +24% | +$273K | ﹤0.01% | 935 |
|
|
2017
Q4 | $1.05M | Sell |
7,015
-182
| -3% | -$26.9K | ﹤0.01% | 1076 |
|
|
2017
Q3 | $1.09M | Buy |
7,197
+456
| +7% | +$68.6K | ﹤0.01% | 1038 |
|
|
2017
Q2 | $869K | Sell |
6,741
-583
| -8% | -$70.2K | ﹤0.01% | 1124 |
|
|
2017
Q1 | $801K | Buy |
7,324
+3,749
| +105% | +$330K | ﹤0.01% | 1187 |
|
|
2016
Q4 | $263K | Sell |
3,575
-13,961
| -80% | -$1.14M | ﹤0.01% | 1678 |
|
|
2016
Q3 | $1.53M | Buy |
17,536
+3,785
| +28% | +$358K | 0.01% | 836 |
|
|
2016
Q2 | $1.18M | Buy |
13,751
+10,530
| +327% | +$910K | ﹤0.01% | 927 |
|
|
2016
Q1 | $256K | Sell |
3,221
-1,381
| -30% | -$125K | ﹤0.01% | 1587 |
|
|
2015
Q4 | $579K | Sell |
4,602
-715
| -13% | -$86.3K | ﹤0.01% | 1237 |
|
|
2015
Q3 | $554K | Buy |
5,317
+1,026
| +24% | +$132K | ﹤0.01% | 1251 |
|
|
2015
Q2 | $530K | Buy |
4,291
+728
| +20% | +$91.7K | ﹤0.01% | 1333 |
|
|
2015
Q1 | $420K | Buy |
3,563
+772
| +28% | +$92.5K | ﹤0.01% | 1433 |
|
|
2014
Q4 | $331K | Buy |
2,791
+1,114
| +66% | +$125K | ﹤0.01% | 1550 |
|
|
2014
Q3 | $189K | Sell |
1,677
-110
| -6% | -$10.5K | ﹤0.01% | 1795 |
|
|
2014
Q2 | $170K | Buy |
1,787
+1,352
| +311% | +$94.8K | ﹤0.01% | 1876 |
|
|
2014
Q1 | $31K | Sell |
435
-1,207
| -74% | -$95.6K | ﹤0.01% | 2671 |
|
|
2013
Q4 | $122K | Sell |
1,642
-3,907
| -70% | -$272K | ﹤0.01% | 1993 |
|
|
2013
Q3 | $421K | Buy |
5,549
+4,886
| +737% | +$389K | ﹤0.01% | 1336 |
|
|
2013
Q2 | $53K | Buy |
+663
| New | +$48.8K | ﹤0.01% | 2298 |
|
Other funds holding VRTX
VCM
VPM
US Bancorp's VRTX Position: Q1 2026 in Review
US Bancorp reduced its Vertex Pharmaceuticals (VRTX) stake by 0.23% in Q1 2026, selling an estimated $32.2K and leaving 29,781 shares worth $13.3M. The position accounts for 0.02% of the portfolio, ranked #365.
US Bancorp first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.6M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- US Bancorp held 29,781 shares of Vertex Pharmaceuticals worth $13.3M as of Q1 2026.
- US Bancorp sold 69 Vertex Pharmaceuticals shares in Q1 2026, an estimated $32.2K.
- Vertex Pharmaceuticals made up 0.02% of US Bancorp's portfolio in Q1 2026, its #365 holding.
- US Bancorp first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- US Bancorp's Vertex Pharmaceuticals position peaked at $15.6M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.